In the United States and most other developed countries, lung cancer is the leading cause of cancer-related death. Notoriously hard to detect in its early stages, the overall five-year survival rate for the disease is only 14 percent. Maik Huttemann, Ph.D., assistant professor of molecular medicine and genetics in Wayne State University's School of Medicine, along with research associate Jeffrey Doan, Ph.D., is working to improve those odds by developing a screening technique for a gene that may be indicative of lung cancer. He is developing a platform technology which utilizes probe ligation and rolling circle amplification to screen for any target gene in many different types of diseases.
"Amplifying Cancer's Signal,"
New Science: Vol. 19
, Article 16.
Available at: http://digitalcommons.wayne.edu/newscience/vol19/iss1/16